150 related articles for article (PubMed ID: 17882283)
1. The history of myeloproliferative disorders: before and after Dameshek.
Tefferi A
Leukemia; 2008 Jan; 22(1):3-13. PubMed ID: 17882283
[TBL] [Abstract][Full Text] [Related]
2. The chronic myeloproliferative disorders: an historical perspective.
Steensma DP
Curr Hematol Rep; 2003 May; 2(3):221-30. PubMed ID: 12901343
[TBL] [Abstract][Full Text] [Related]
3. The 2001 World Health Organization and updated European clinical and pathological criteria for the diagnosis, classification, and staging of the Philadelphia chromosome-negative chronic myeloproliferative disorders.
Michiels JJ; De Raeve H; Berneman Z; Van Bockstaele D; Hebeda K; Lam K; Schroyens W
Semin Thromb Hemost; 2006 Jun; 32(4 Pt 2):307-40. PubMed ID: 16810609
[TBL] [Abstract][Full Text] [Related]
4. [Diagnosis and treatment of BCR/ABL-negative myeloproliferative diseases--principles and rationale of CZEMP recommendations].
Schwarz J; Penka M; Campr V; Pospísilová D; Kren L; Nováková L; Bodzásová C; Brychtová Y; Cerná O; Dulícek P; Joniásová A; Kissová J; Korístek Z; Schützová M; Vonke I; Walterová L
Vnitr Lek; 2011 Feb; 57(2):189-213. PubMed ID: 21416861
[TBL] [Abstract][Full Text] [Related]
5. Kinase drug discovery approaches in chronic myeloproliferative disorders.
Kumar C; Purandare AV; Lee FY; Lorenzi MV
Oncogene; 2009 Jun; 28(24):2305-13. PubMed ID: 19421140
[TBL] [Abstract][Full Text] [Related]
6. Myeloproliferative disorders.
Levine RL; Gilliland DG
Blood; 2008 Sep; 112(6):2190-8. PubMed ID: 18779404
[TBL] [Abstract][Full Text] [Related]
7. The 2008 World Health Organization classification system for myeloproliferative neoplasms: order out of chaos.
Tefferi A; Thiele J; Vardiman JW
Cancer; 2009 Sep; 115(17):3842-7. PubMed ID: 19472396
[TBL] [Abstract][Full Text] [Related]
8. Beyond chronic myelogenous leukemia: potential role for imatinib in Philadelphia-negative myeloproliferative disorders.
Cortes J; Kantarjian H
Cancer; 2004 May; 100(10):2064-78. PubMed ID: 15139047
[TBL] [Abstract][Full Text] [Related]
9. Numerical gain and structural rearrangements of JAK2, identified by FISH, characterize both JAK2617V>F-positive and -negative patients with Ph-negative MPD, myelodysplasia, and B-lymphoid neoplasms.
Najfeld V; Cozza A; Berkofsy-Fessler W; Prchal J; Scalise A
Exp Hematol; 2007 Nov; 35(11):1668-76. PubMed ID: 17976519
[TBL] [Abstract][Full Text] [Related]
10. Oncogenes in myeloproliferative disorders.
Tefferi A; Gilliland DG
Cell Cycle; 2007 Mar; 6(5):550-66. PubMed ID: 17351342
[TBL] [Abstract][Full Text] [Related]
11. Advances in the molecular characterization of Philadelphia-negative chronic myeloproliferative disorders.
Pikman Y; Levine RL
Curr Opin Oncol; 2007 Nov; 19(6):628-34. PubMed ID: 17906464
[TBL] [Abstract][Full Text] [Related]
12. Pathogenetic mechanisms in chronic myeloproliferative disorders: polycythemia vera, essential thrombocythemia, agnogenic myeloid metaplasia, and chronic myelogenous leukemia.
Tefferi A
Semin Hematol; 1999 Jan; 36(1 Suppl 2):3-8. PubMed ID: 9930550
[TBL] [Abstract][Full Text] [Related]
13. [Essential thrombocythemia. Contribution of the V617F JAK2 mutation to the pathophysiology, diagnosis and outcome].
Brière J
Bull Acad Natl Med; 2007 Mar; 191(3):535-48. PubMed ID: 18072652
[TBL] [Abstract][Full Text] [Related]
14. Oncogenic signals as treatment targets in classic myeloproliferative neoplasms.
Tefferi A; Levine RL; Kantarjian H
Biol Blood Marrow Transplant; 2009 Jan; 15(1 Suppl):114-9. PubMed ID: 19147089
[TBL] [Abstract][Full Text] [Related]
15. Imatinib and tyrosine kinase inhibition, in the management of BCR-ABL negative myeloproliferative disorders.
Mesa RA
Biologics; 2007 Jun; 1(2):129-38. PubMed ID: 19707323
[TBL] [Abstract][Full Text] [Related]
16. bcr gene rearrangement analysis in myeloproliferative disorders other than chronic myelogenous leukemia.
Crisan D; Mattson JC; O'Malley BA; Schulz RW; Wilner F
Cancer Detect Prev; 1996; 20(4):263-9. PubMed ID: 8818385
[TBL] [Abstract][Full Text] [Related]
17. Me, myself, and I: the rise of the modern self.
Hanna R; Izenberg G; Martin R; Wiley N; Seigel J
Ann N Y Acad Sci; 2011 Oct; 1234():108-20. PubMed ID: 21988257
[TBL] [Abstract][Full Text] [Related]
18. Endometriosis: ancient disease, ancient treatments.
Nezhat C; Nezhat F; Nezhat C
Fertil Steril; 2012 Dec; 98(6 Suppl):S1-62. PubMed ID: 23084567
[No Abstract] [Full Text] [Related]
19. Isis current bibliography of the history of science and its cultural influences, 2009.
Isis; 2009; 100 Suppl():1-224. PubMed ID: 20422771
[No Abstract] [Full Text] [Related]
20. Isis current bibliography of the history of science and its cultural influences, 2008.
Isis; 2008; 99 Suppl():1-320. PubMed ID: 19388189
[No Abstract] [Full Text] [Related]
[Next] [New Search]
